The developing sinus venosus myocardium, derived from the posterior heart field, contributes to the atrial septum, the posterior atrial wall, the sino-atrial node, and myocardium lining the pulmonary and cardinal veins, all expressing podoplanin, a coelomic and myocardial marker. We compared development and differentiation of the myocardium and vascular wall of the pulmonary veins (PV), left atrial dorsal wall, and atrial septum in wild type with podoplanin knockout mouse embryos (E10.5-E18.5) by 3D reconstruction and immunohistochemistry. Expression of Nkx2.5 in the pulmonary venous myocardium changes from mosaic to positive during development pointing out a high proliferative rate compared with Nkx2.5 negative myocardium of the sino-atrial node and cardinal veins. In mutants, myocardium of the PVs, dorsal atrial wall and atrial septum was hypoplastic. The atrial septum and right-sided wall of the PV almost lacked interposed mesenchyme. Extension of smooth muscle cells into the left atrial body was diminished. We conclude that myocardium of the PVs, dorsal atrial wall, and atrial septum, as well as the smooth muscle cells, are derived from the posterior heart field regulated by podoplanin. (Pediatr Res 65: 27-32, 2009) T he developmental origin and molecular mechanisms controlling the formation of the myocardium of the pulmonary veins (PV) and the smooth muscle cells (SMCs) of the PV media are a matter of debate. The PV myocardial sleeve develops by either migration of myocardial cells from the left atrium (LA) (1) or by recruitment of extracardiac mesenchymal cells, which differentiate into myocardial cells (2). Based on expression patterns of Nkx2.5, Islet1, and Pitx2c the LA and PV myocardium was suggested to be formed by the addition of myocardial cells from the second heart field at the venous pole (3).
T he developmental origin and molecular mechanisms controlling the formation of the myocardium of the pulmonary veins (PV) and the smooth muscle cells (SMCs) of the PV media are a matter of debate. The PV myocardial sleeve develops by either migration of myocardial cells from the left atrium (LA) (1) or by recruitment of extracardiac mesenchymal cells, which differentiate into myocardial cells (2) . Based on expression patterns of Nkx2.5, Islet1, and Pitx2c the LA and PV myocardium was suggested to be formed by the addition of myocardial cells from the second heart field at the venous pole (3) .
The second heart field, part of the splanchnic mesoderm, is involved in the addition of (myocardial) cells to the primary heart tube at both the arterial (the secondary and anterior heart field) and the venous pole (the posterior heart field) (4) . Islet1, a marker of undifferentiated cardiac progenitor cells, is expressed throughout the second heart field (5). Myocardial cells can differentiate from second heart field derived mesenchymal cells, and SMCs may also differentiate from mesenchyme (6) .
The transmembrane glycoprotein podoplanin, a coelomic and myocardial marker expressed in the posterior heart field (7), has gained interest for its role in epithelial-tomesenchymal transformation (EMT) and in formation of the myocardium and coronary SMCs at the venous pole of the heart (8) . It is found in the proepicardial organ, epicardium, and sinus venosus myocardium including the sino-atrial node, the PVs and cardinal veins, the dorsal atrial wall and the base of the atrial septum extending into the developing atrial and ventricular cardiac conduction system. Podoplanin promotes EMT by binding ezrin, radixin, moesin (ERM) proteins that activate RhoA, and by down-regulation of the cell-to-cell adhesion molecule E-cadherin (9) . Lack of podoplanin leads to altered EMT and to abnormal formation of sinus venosus myocardium and decreased numbers of SMCs of the coronary artery media (8) . In extracardiac tissues, podoplanin functions as a possible signaling molecule and is involved in the development of osteoblasts (10) , intestinal and alveolar epithelium (11) , podocytes and mesothelium of the visceral peritoneum (12) , and lymphatic endothelium (13) . During cardiac development, podoplanin is expressed specifically in the second heart field-derived myocardium and mesenchyme at the venous pole of the heart (7, 8) .
Our previous study in humans (14) demonstrated that during incorporation of the PVs in the LA body, the inner lining of the LA body presents vessel wall tissue. The outer layer of the LA is formed by myocardium covered by epicardium. The origin of the SMCs of the LA dorsal wall is still a topic of discussion.
In the present study, we have compared the morphology and development of the wall of the PVs, LA dorsal wall, and atrial septum between wild type and podoplanin knockout mouse embryos of embryonic stages (E) 10.5-18.5. We hypothesize that the posterior heart field is involved in the formation and differentiation of both myocardial cells and SMCs of the PVs and LA dorsal wall regulated by podoplanin.
MATERIALS AND METHODS
Generation of the embryonic and neonatal mice. This study was performed at the Department of Anatomy and Embryology of the Leiden University Medical Center, and was approved by the Animal Research Committee. Podoplanin knockout mice were generated by homologous recombination in embryonic stem cells from the 129S/v mouse line, as reported previously (8) .
General description. We investigated the morphology and development of the sinus venosus region of the heart, especially the PVs, LA dorsal wall, and atrial septum in 32 wild-type mouse embryos of E10.5 (n ϭ 4), E11.5 (n ϭ 3), E12.5 (n ϭ 4), E13.5 (n ϭ 5), E14.5 (n ϭ 4), E15.5 (n ϭ 3), E16.5 (n ϭ 3), E17.5 (n ϭ 3), and E18.5 (n ϭ 3), and compared these with 28 podoplanin knockout mouse embryos of E10.5 (n ϭ 4), E11.5 (n ϭ 5), E12.5 (n ϭ 5), E13.5 (n ϭ 3), E14.5 (n ϭ 4), E15.5 (n ϭ 4), and E18.5 (n ϭ 3).
Immunohistochemistry. Immunohistochemistry was performed with antibodies against alpha-smooth-muscle actin (1A4, 1:2000, Sigma Chemical Co. Aldrich, Product No.A2547, USA) to detect differentiated SMCs and developing myocardium, atrial myosin light chain 2 (MLC2a, 1/6000, kindly provided by S.W. Kubalak, Charleston, SC) specific for (atrial) myocardium, NK2 transcription factor related locus 5 (Nkx2.5, 1/4000, Santa Cruz Biotechnology, CA, SC-8697) as an early marker of undifferentiated cardiac progenitor cells, and podoplanin (clone 8.1.1., 1/500, Hybridomabank, IA) as a marker of the posterior heart field myocardium. Fixation, preparation, and staining procedures were completed according to standard protocols (8) .
3D reconstructions. We made 3D reconstructions, as described previously (8), of the composition of PV, LA dorsal wall, and atrial septum of MLC-2a and 1A4 stained sections of podoplanin wild-type and knockout embryos (E15.5).
Morphometry. Sinus venosus myocardial volume estimation was performed of 12 wild-type mouse hearts of E11.5 (n ϭ 3), E12.5 (n ϭ 3), E15.5 (n ϭ 3), and E18.5 (n ϭ 3) and 12 podoplanin knockout hearts of E11.5 (n ϭ 3), E12.5 (n ϭ 3), E15.5 (n ϭ 4), and E18.5 (n ϭ 2). Statistical analysis was performed with an independent sample t test (p Ͻ 0.05) using SPSS 11.0 software (SPSS Inc, Chicago, IL), as described previously (8) .
RESULTS
Podoplanin mutants demonstrate marked mesenchymal and myocardial abnormalities, including hypoplasia of the proepicardial organ, abnormal epicardium, hypoplastic chamber myocardium, atrial, ventricular and atrioventricular septal defects, and an abnormal coronary arterial vascular wall (7, 8) . These abnormalities are related to diminished EMT, which was reported in a previous article (8) . Later, the morphologic development of the wall of the PV, LA, and atrial septum will be described in subsequent stages. Abnormal PV connections were not observed. In Table 1 , sinus venosus myocardial volumes between wild-type and knockout mice are compared. Table 2 provides an overview of qualitative expression of myocardial and SMCs markers used. E10.5. In the right part of the common atrium, the right and left venous valves delineated the ostia of the cardinal veins entering the sinus venosus. In both wild-type and knockout embryos, MLC2a was expressed in the sinus venosus and chamber myocardium (Fig. 1a, c-e ). In the mesenchyme of the dorsal mesocardium in wild-type embryos, the lumen of the primitive PV was surrounded by a mainly left sided concentration of MLC2a positive myocardium that stained, however, less markedly for MLC2a compared with the common atrium (Fig. 1a, d ). In knockouts, this myocardium was thinner with clearly diminished MLC2a expression in a larger part in the dorsal mesocardium and left part of the atrial dorsal wall (compare Fig. 1d with e). This diminished expression was seen in the region normally expressing podoplanin (Fig. 1b 
A qualitative overview of the expression of markers at several locations in podoplanin WT and knockout (KO) embryos. At early stages, the expression of all markers is diminished in mutants compared to the WT embryos, whereas in advanced stages these differences are no longer apparent, indicating delayed differentiation in mutants.
LA, left atrium; PV, pulmonary vein; ϩϩϩ, strong; ϩϩ, medium; ϩ, weak; -, absent expression. Table 2 ). In wild types, the primitive PV myocardium in the region of the dorsal mesocardium had mosaic Nkx2.5 expression, defined as a mixture of Nkx2.5 positive and negative cells. Similar to MLC2a expression, the Nkx2.5 mosaic myocardial cells were mainly situated on the left side of the dorsal mesocardium (Fig. 1f) . Moreover, in knockouts, this area was hypoplastic showing less Nkx2.5 expressing cells (compare Fig. 1f with g ). The alpha-smooth-muscle actin antibody 1A4 was coexpressed in the MLC2a-stained myocardium of the common atrium and ventricle of the wild-type embryos. Similar to MLC2a, actin expression around the primitive PV and left part of the atrial dorsal wall was weaker (Fig. 1h) . In mutants, actin expression was diminished in a larger region compared with the wild type (Fig. 1i) .
E12.5. The common PV bifurcated into tiny left and right
PVs, covered by a MLC2a-positive myocardial layer, which, in contrast to E10.5, could now be observed in equal density on both sides of the PV (Fig. 2a, c) . MLC2a expression around the PV was weaker than the expression in the myocardium of the atria (Fig. 2a, c) . In the dorsal mesocardium and around the PV, Nkx2.5 expression was mosaic, whereas in the wall of the cardinal veins Nkx2.5 staining was negative (Fig. 2d) . In the atrial myocardium of the wild-type embryos, MLC2a and Nkx2.5 were positive, whereas smooth muscle actin had almost disappeared, particularly in the LA dorsal wall (Fig. 2e) . In the myocardium of the ventricles (not shown) and in the wall of the cardinal veins (Fig. 2e) , smooth muscle actin was still present. Actin expression in the wall of the PV was more extensive than the MLC2a expression (Fig. 2e) .
In the podoplanin knockout embryos, MLC2a (Fig. 2f, g ) and actin positive (Fig. 2i) as well as Nkx2.5 mosaic (Fig. 2h ) myocardium around the PV was thin and locally even absent (compare Fig. 2a , c with f, g) in a region where podoplanin expression was seen in wild-type embryos (Fig. 2b) . The LA dorsal wall and the atrial septum were thin and the myocardium was hypoplastic (compare Fig. 2j, k with l, m) . The atrial septum showed a large secondary foramen and myocardialization at the base of the atrial septum was absent (Fig. 2k, m) . Additionally, the atrioventricular cushion was not fused properly to the top of the ventricular septum resulting in an interventricular communication (Fig. 2j, l) . E15.5. In both wild types and knockouts, the myocardium of the atria, the atrial septum and of the wall of the cardinal, and PVs expressed MLC2a (Fig. 3a-f) . In mutants, the myocardium of the atrial septum and the PVs was hypoplastic (compare Fig. 3c, d with e, f) . Moreover, compared with wild type, the PVs in the knockout embryos seemed to be dilated (compare Fig. 3c with e) . In both wild-type and knockout embryos, the Nkx2.5 mosaic expression in the wall of the PV became overall positive (Fig. 3g, i) .
In wild-type embryos, 1A4 costaining was specifically observed in the MLC2a positive subendothelial layer of the PVs and LA dorsal wall (Fig. 3h) . In the outer MLC2a positive myocardial layer of the wall of the PVs, cardinal veins, dorsal atrial wall, and the entire atrial myocardium (not shown) 1A4 staining had disappeared (Fig. 3h) . In knockout embryos, smooth muscle actin was almost absent in the subendothelial layer of the PVs and LA dorsal wall, which still showed MLC2a staining (compare Fig. 3a, h with b, j) . In areas with 1A4 expression, distribution of positive cells was discontinuous compared with the wild-type embryos (compare Fig. 3h with j) . E18.5. The common part of the PVs was incorporated into the LA. In both wild-type and knockout embryos, MLC2a expressing myocardium was seen in the atria and the wall of the cardinal and PVs, whereas the myocardium now extended into the lungs (Fig. 4a, b) . Similar to previous stages, the myocardium was hypoplastic in knockouts, with dilation of the atria, the cardinal, and PVs (compare Fig. 4a, b with c, d ). In the dorsal mesocardium, less mesenchymal cells were observed compared with the wild type (compare asterisk in Fig. 4a with b) . In the PV and LA dorsal wall of the wild-type embryos, smooth muscle actin (1A4) was present between endothelium and MLC2a positive myocardium (Fig. 4e) . Hence, the 1A4 positive actin layer was MLC2a negative in contrast to the previous stages (compare Fig. 3d, h with Fig. 4c, e) . The 1A4 staining at other parts of the heart was absent (not shown), except for the wall of the cardinal veins and ventricular myocardium. Again, hardly any 1A4 staining was seen in the subendothelial layer of the PV and LA dorsal wall of the podoplanin knockout embryos (compare Fig. 4e with f) .
DISCUSSION
During human development, a vascular lining comprising SMCs and an adventitia will evolve at the inside of the LA body that is lined on the outside by atrial myocardium (14) . Findings in the current study show a similar phenomenon in the LA of wild-type mouse embryos. A difference between mouse and human specimen concerns the extension of the myocardial tissue surrounding the PV into the lung. The merits of our current study are that the posterior heart field plays a role in the addition of not only PV myocardium, but also in the formation and differentiation of SMCs that line the LA body. We demonstrated hypoplasia of the myocardium of the PV, LA dorsal wall, and the atrial septum in podoplanin knockout mice. The vessel wall of the PVs and its extension into the LA was underdeveloped in knockout embryos.
Myocardial development. It has been reported earlier that the myocardial sleeve around the PV is formed by either migration of existing atrial cardiomyocytes (1) or by recruitment and differentiation of mesenchymal cells of the splanchnic mesoderm (2) . The latter supports earlier advances in the study of cardiac development that underline the relevance of addition of myocardium to the primary heart tube (15). The second heart field (5) or second lineage (5,4) concerns an anteroposterior extension of splanchnic mesenchyme from where cells are recruited for addition to both the arterial pole and the venous pole of the heart. Several studies have been performed using different lineage markers such as fibroblast growth factor (Fgf) 8 and 10 (16), Islet (Isl)1 (5), and Tbx1 and 18 (17, 18) to trace these cells into their cardiac destination. Special interest was raised in markers specific for recruitment of myocardium from the second heart field to the venous pole of the heart such as Pitx2c (3), Nkx2.5 (3,7), Shox2 (19) , and podoplanin (7, 8) .
Podoplanin promotes EMT by binding ERM proteins that activate RhoA and by down-regulation of the cell-to-cell adhesion molecule E-cadherin (8, 9) . In podoplanin knockout mice, E-cadherin is up-regulated causing abnormal EMT, which may lead to abnormal formation of myocardium at the venous pole of the heart (8). Thus, the hypoplasia of the myocardium of the wall of the PVs, atrial septum, and LA dorsal wall observed in the current study in podoplanin knockout mice could be explained by impaired addition of myocardium from the posterior heart field because of abnormal EMT by lack of podoplanin.
Another explanation for the myocardial hypoplasia in the podoplanin knockouts could be abnormal epicardialmyocardial interaction. Previously, we demonstrated that altered epicardial-myocardial interaction leads to deficient ventricular myocardial formation in SP3 mutants (20) as well as in podoplanin mutant embryos (8) . In SP3 mutants, WT-1 expression, a transcription factor involved in development of epicardium derived cells (EPDCs) (21) was down-regulated and the mutant hearts showed EPDC-related cardiac abnormalities comparable with podoplanin mutants. The impaired formation of EPDCs and altered epicardial-myocardial inter- action, resulting in hypoplastic atrial and ventricular myocardium in podoplanin knockouts, has already been described and related to the deficient contribution of the posterior heart field (8, 22) . Therefore, the hypoplasia of the PVs, atrial septum, and LA dorsal wall reported in the current study could be related to the altered contribution of epicardium and myocardium from the posterior heart field.
In early stages, Nkx2.5 and alpha-smooth-muscle actin (1A4) are expressed in undifferentiated myocardium. At these stages, Nkx2.5 is mosaic around the PVs and absent in the wall of the cardinal veins (7), whereas actin expression is present in the wall of the pulmonary and cardinal veins. The Nkx2.5 mosaic expression in the wall of the PVs rapidly becomes completely positive concomitant with a higher proliferation rate of the PV myocardium compared with the cardinal veins (3). Consequently, 1A4 expression from E15.5 is confined to the medial layer of the vascular wall of the pulmonary and cardinal veins. These findings suggest that the pulmonary and cardinal veins have a common precursor derived from the posterior heart field (7), but a distinct proliferation (3) rate accounting for a distinct differentiation based on Nkx2.5 expression.
Expression of markers in putative PV myocardium starts at the left side of the dorsal mesocardium, indicating that PV myocardium is preferentially added from the left side of the posterior heart field regulated by progenitor cells that play a role in left-right patterning, as was reported for Pitx2c (3, 23, 24) . Next to hypoplasia, mutants showed diminished expression, which was predominantly observed in the earlier stages (Tables 1 and 2 ). As in later stages, these differences were no longer apparent, this suggests a delayed differentiation of the myocardium and SMCs in mutants.
Smooth muscle cell development. The origin of the SMCs at the venous pole is as yet not well understood. SMCs may differentiate from mesenchymal cells (6) . At the arterial pole, formation and differentiation of SMCs has been reported from the splanchnic mesoderm or from the neural crest (25) . The latter process requires cross-talk between the endothelial and the muscular component (26) . DeRuiter et al. (27) have described the formation of the SMCs of the dorsal aorta by transdifferentiation from endothelial cells. Research in this field is complicated as alpha-smoothmuscle actin also stains the primitive myocardium. We demonstrated that this staining was less extensive in developing myocardium of the podoplanin mutant mice, supporting delayed or defective myocardial differentiation. At stage [15] [16] [17] [18] in which alpha-smooth-muscle actin disappears from the myocardium, only the SMCs retain their expression of this marker. In podoplanin knockout mice, we observed a diminished extension of SMCs in the LA dorsal wall compared with normal. This phenomenon may be caused by impaired formation of SMCs from the posterior heart field-derived dorsal mesocardium or abnormal or delayed differentiation of the SMCs in the PV and LA body in absence of podoplanin. The disturbed EMT in podoplanin knockouts probably leads to abnormal formation of SMCs, as was shown for the coronary artery SMCs development in mutant mice (8) .
In conclusion, as podoplanin is a marker of the myocardial and mesenchymal cells derived from the second heart field at the venous pole of the heart, this study supports evidence that the myocardium of the PVs, LA dorsal wall, and atrial septum is derived from the posterior heart field. Moreover, we can state that podoplanin not only plays a role in the development of myocardium, but also in the formation of the SMCs.
The clinical relevance of our findings needs further research. In the mutants, complex atrial defects were observed. In the majority, there was fusion of the primary atrial septum with the AV cushions, but the secondary foramen was enlarged and the AV cushions did not fuse properly with the ventricular septum resulting in an AVSD with shunting at the ventricular level. These findings were described in a previous study (8) . The study of human and mouse models with isomerism, atrial arrhythmias, and cases with abnormal pulmonary venous return are on their way. More insight into the variation in myocardial cuffing of the PVs in the human population might enlighten us on the variability of occurrence of ectopic automaticity in the PV myocardial sleeve (28) , which is suggested by the finding that the length of the PV sleeve corresponds to the frequency of occurrence of ectopic PV beats as observed in electrophysiological studies (28, 29) . In podoplanin knockout embryos, we have observed deficient sinus venosus myocardium with myocardial discontinuities. Areas lacking myocardium can be regarded as low voltage areas (comparable with scar tissue) that may form the substrate of reentry circuits. Electrophysiological testing in mutant mice is necessary to further investigate this hypothesis.
